[{"id":"8eae4547-c419-42bc-bcef-a0c556fe5a48","acronym":"REVOCAN","url":"https://clinicaltrials.gov/study/NCT04826198","created_at":"2021-04-01T16:52:33.019Z","updated_at":"2024-07-02T16:35:51.390Z","phase":"Phase 1/2","brief_title":"Safety and Efficacy of AsiDNATM, a DNA Repair Inhibitor, Administered Intravenously in Addition to PARP Inhibitors in Patients With Relapsed Platinum Sensitive Ovarian Cancer Already Treated With PARP Inhibitors Since at Least 6 Months","source_id_and_acronym":"NCT04826198 - REVOCAN","lead_sponsor":"Gustave Roussy, Cancer Campus, Grand Paris","biomarkers":" BRCA • MUC16","pipe":"","alterations":" ","tags":["BRCA • MUC16"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Lynparza (olaparib) • Zejula (niraparib) • Rubraca (rucaparib) • AsiDNA (etidaligide)"],"overall_status":"Recruiting","enrollment":" Enrollment 26","initiation":"Initiation: 10/05/2020","start_date":" 10/05/2020","primary_txt":" Primary completion: 10/01/2023","primary_completion_date":" 10/01/2023","study_txt":" Completion: 10/01/2023","study_completion_date":" 10/01/2023","last_update_posted":"2023-04-05"},{"id":"d8f465db-29ac-4ca7-bf00-d3ee8cdb5495","acronym":"","url":"https://clinicaltrials.gov/study/NCT05700669","created_at":"2023-01-26T15:02:54.849Z","updated_at":"2024-07-02T16:35:51.737Z","phase":"Phase 1b/2","brief_title":"Study To Assess Safety And Efficacy Of AsiDNA In Combination With Olaparib In Participants With Recurrent Solid Tumors","source_id_and_acronym":"NCT05700669","lead_sponsor":"Onxeo","biomarkers":" HER-2 • PGR","pipe":" | ","alterations":" HER-2 positive • HR positive • PGR positive","tags":["HER-2 • PGR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 positive • HR positive • PGR positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Lynparza (olaparib) • AsiDNA (etidaligide)"],"overall_status":"Recruiting","enrollment":" Enrollment 115","initiation":"Initiation: 02/20/2023","start_date":" 02/20/2023","primary_txt":" Primary completion: 12/01/2026","primary_completion_date":" 12/01/2026","study_txt":" Completion: 04/01/2027","study_completion_date":" 04/01/2027","last_update_posted":"2023-03-31"}]